LabWare Named Best IT Solution at the Labmate Awards for Excellence 2025
Exhibitor: LABWARE TAIWAN CO., LTD.
Date: 2026-06-22
Booth No.: L1207
LabWare is honored to be named Best IT Solution in the Labmate Awards for Excellence 2025. This accolade reflects the global laboratory community’s endorsement of the company’s unwavering commitment to innovation, quality and seamless digital transformation. Recognition in the Best IT Solution category underscores LabWare’s ability to meet evolving scientific and regulatory demands while empowering researchers and quality teams to achieve breakthrough results.
Labmate Awards for Excellence 2025: A Spotlight on Breakthrough Innovations
The Labmate Awards for Excellence 2025 celebrates leading laboratory products and service providers, recognizing achievements across 11 distinct categories that highlight a great variety of contributions made across the industry over the past twelve months. Voting was open to global laboratory professionals, resulting in participation from six continents and showcasing broad industry engagement with this year’s awards process.
Best IT Solution: A Showcase of Digital Leadership
The Best IT Solution category highlights platforms that drive data integrity, streamlined workflows and leverage emerging technologies. Nominees were evaluated on innovation, configurability, user experience and regulatory compliance. In the Best IT Solution category, LabWare secured top honors for its Enterprise Laboratory Platform. This award reflects high praise from end users through a meticulous voting process led by Labmate’s editorial team.
Driving Innovation in Lab Informatics
LabWare’s Enterprise Laboratory Platform combines Laboratory Information Management Systems (LIMS), Electronic Laboratory Notebooks (ELN), and mobile solutions in a unified, highly configurable suite. Advanced data analytics, machine learning, and AI capabilities empower labs to unlock new insights and drive scientific breakthroughs.
Unmatched Customer Satisfaction and Support
A customer satisfaction rate of 98 percent reflects the effectiveness of LabWare’s global implementation and support framework. This high rating underscores rapid deployment, rigorous validation protocols and audit-ready workflows designed to meet regulatory requirements.
Support for over 29,000 laboratories in more than 100 countries demonstrates the scalability and adaptability of LabWare’s solutions. The platform’s flexible architecture and extensive integration capabilities facilitate seamless connectivity with instruments and enterprise systems, fostering global collaboration and insight sharing.
Future Outlook: Shaping the Next Era of Digital Laboratories
Building on this recognition, LabWare celebrates its contributions to the laboratory sector and continues pursuing excellence in IT solutions. As laboratories worldwide embrace digital transformation, LabWare remains positioned to drive innovation, compliance and scientific excellence into the next decade.
More Exhibitor's Press Release
- Next Generations Therapy Manufacturing LEVITRONIX GMBH TAIWAN BRANCH / 2026-06-17
- The Fastest and Safest Depth Filtration LEVITRONIX GMBH TAIWAN BRANCH / 2026-06-17
- Highest Cell Viability in Perfusion LEVITRONIX GMBH TAIWAN BRANCH / 2026-06-17
- Wireless × Complete Recording × Traceability BrainChild DRS Powers Smarter Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-06-16
- BrainChild PRV2.0 Precision Measurement Built for Accuracy, Reliability and Better Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-06-16
- BrainChild XH13 Cloud Logger Delivers Environmental Visibility for Labs and Storage BRAINCHILD ELECTRONIC CO., LTD. / 2026-06-16
- Bridging the U.S. and Global Markets: EG BioMed Builds an International Precision Cancer Testing Ser EG BIOMED US INC. / 2026-06-15
- Blood-Based Early Cancer Detection: Advancing Precision Health Through DNA Methylation Science EG BIOMED US INC. / 2026-06-15
- EG BioMed U.S. CLIA/CAP-Certified Laboratory Opens Partnership Opportunities EG BIOMED US INC. / 2026-06-15
- 2026 BIO Asia: Next-Gen 3D Cell Culture & Exosome Solutions by LIS TECH & GeniCore Biotech LIS TECH CO., LTD. / GENICORE BIOTECH / 2026-06-04
- Botanical Drug GM-XANTHO® Completes Phase I/IIa Trial for Atopic Dermatitis XANTHO BIOTECHNOLOGY CO., LTD. / 2026-06-04
- ProBio and Curocell Achieve Key CAR-T Milestone with BLA Regulatory Approval and Commercial Readines PROBIO TECHNOLOGY HK LIMITED. / 2026-06-04
- LIS TECH Showcases Regenerative Medicine and Bioprocessing Platform at BIO Asia–Taiwan 2026 LIS TECH CO., LTD. / GENICORE BIOTECH / 2026-06-03
- GeniCore Biotech Unveils Its AI-Powered Genimer™ Aptamer Platform LIS TECH CO., LTD. / GENICORE BIOTECH / 2026-06-03
- Medidata’s Digital Oversight Platform Empowers Pharma and CROs to Align with Next-Gen GCP MEDIDATA / 2026-06-02
- Medidata Powers Transformational Breakthroughs in Over 500 Global Clinical Trials with AI MEDIDATA / 2026-06-02
- Empowering eCOA to Deliver Flexible and Efficient Digital Solutions MEDIDATA / 2026-06-02
- Save the Date: LabWare Professional Seminar Coming This September! LABWARE TAIWAN CO., LTD. / 2026-05-29
- SimTissue® by Lyson: The One-Stop Phantom Solution for Advanced Surgical Simulation LYSON MEDICAL TECHNOLOGY / 2026-05-27
- Top-Tier Laboratory Equipment Expert "Chuan Fu Technology" to Spark Innovation at BIO Asia-Taiwan CHUNG FU TECHNICAL DEVELOPMENT CO., LTD. / 2026-05-27